Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.
Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...